Us nasal spray market

U.S. Nasal Spray Market, By Product Type (Steroid Sprays, Antihistamine Sprays, Decongestant Sprays, Others), By Type (Prescription and Over-the-Counter), By Indication (Allergic Rhinitis, Nasal Allergies, Nasal Congestion, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Apr 2024
  • CMI5261
  • 174 Pages
  • Excel & Pdf
  • Pharmaceutical
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Type
      • Market Snapshot, By Indication
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Product Launches/Approvals
    • Recent Developments
    • Regulatory Scenario
    • Technological Advancements
    • Manufacturer Revenue
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. U.S. Nasal Spray Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 impact on the market
  5. U.S. Nasal Spray Market, By Product Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Steroid Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Antihistamine Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Decongestant Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. U.S. Nasal Spray Market, By Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Prescription
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Over-the-Counter
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. U.S. Nasal Spray Market, By Indication, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Allergic Rhinitis
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Nasal Allergies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Nasal Congestion
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. U.S. Nasal Spray Market, By Distribution Channel, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  9. Competitive Landscape
    • Company Profiles
      • Sanofi*
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GSK plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • NeilMed Pharmaceuticals Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Neurelis, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GLENMARK PHARMACEUTICALS LTD.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bausch Health Companies Inc. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Viatris Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • The Procter & Gamble Company 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cipla
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • EMERGENT 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hikma Pharmaceuticals PLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 25 figures on “Nasal Spray Market” -U.S. forecast to 2031

Detailed Segmentation-

  • By Product Type:
    • Steroid Sprays
    • Antihistamine Sprays
    • Decongestant Sprays
    • Others
  • By Type:
    • Prescription
    • Over-the-Counter
  • By Indication:
    • Allergic Rhinitis
    • Nasal Allergies
    • Nasal Congestion
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
- Frequently Asked Questions -

What is the CAGR of U.S. nasal spray market during the forecast period?

The CAGR of U.S. nasal spray market is projected to be 6.9% from 2024 to 2031.

What are the major factors driving the U.S. nasal spray market growth?

Rising prevalence of allergic rhinitis and increased diagnosis and treatment seeking behaviour are the major factors driving the growth of U.S. nasal spray market.  

What are the key factors hampering growth of the U.S. nasal spray market?

Strong competition from alternative drug delivery methods and side effects associated with long-term use are the major factors hampering the growth of U.S. nasal spray market.

Which is the leading product type segment in the U.S. nasal spray market?

In terms of product type, antihistamine sprays segment is estimated to dominate the market in 2024.

Which are the major players operating in the U.S. nasal spray market?

Sanofi, GSK plc., Merck & Co., Inc., Novartis AG, Pfizer Inc., AstraZeneca, NeilMed Pharmaceuticals Inc., Neurelis, Inc., Johnson & Johnson Services, Inc., Bayer AG, GLENMARK PHARMACEUTICALS LTD., Bausch Health Companies Inc., Viatris Inc., The Procter & Gamble Company, Cipla, EMERGENT, Hikma Pharmaceuticals PLC are the major players.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.